Nimbus Therapeutics has partnered with Eli Lilly in a multi-year agreement to develop AI-driven oral treatments for metabolic diseases. The deal, including potential payments of $1.3 billion, aims to ...

Losing weight is a top New Year’s resolution. But this year, doctors might prescribe more than just diet and exercise.

Weight-loss drugs are booming (1) and you’ve probably heard of them: Wegovy, Ozempic, Mounjaro, Zepbound. These GLP-1 medications are helping Americans slim down and manage diabetes — and in some ...

WW International (WW), more commonly known as Weight Watchers, is fully embracing the popularity of GLP-1s and their impact on weight loss management with a new platform that integrates GLP-1 ...